MedCognetics, Inc.

MedCognetics is a digital health company that develops advanced AI-powered software platforms designed to integrate into radiology workflows. Their primary focus is on improving breast cancer screening and diagnostics by using machine learning algorithms trained on diverse global patient datasets to mitigate data bias and improve diagnostic accuracy across all ethnicities. The company's flagship technology, including the FDA-cleared CogNet AI-MT and CogNet AI-MT+ platforms, assists radiologists by prioritizing mammography cases with suspicious findings. By enhancing clinical efficiency and reducing radiologist burnout, MedCognetics aims to improve patient outcomes and increase access to high-quality breast cancer screening.